INTRODUCTION
Dengue fever (DF) is an acute febrile illness caused by dengue viruses (DEN-1 to 4) belonging to the family Flaviviridae. An estimated 50 million dengue infections occur annually, and approximately 2.5 billion people live in dengue endemic countries. 1 Several outbreaks of DF have been reported from India.
2,3,4 DEN-2 and DEN-3 are frequently associated with severe disease accompanying secondary DF. 5 Dengue viruses are transmitted to humans through the bite of infected Aedes mosquit oes, principally Aedes aegypti.
Infectious virus and the virus-encoded NS1 are present in blood during the acute phase, and high level early viraemia and NS1 antigenaemia have been associated with more severe clinical presentations. 6 Dengue has become endemic in parts of the world due to rapid urbanization, with increased population density with an abundance of vector breeding sites.
gastroenteritis. Patients with dengue fever may not have specific localizing symptoms at the time of presentation. It is important to diagnose the aetiological agent in acute pyrexia quickly to prevent complications like shock and bleeding in dengue fever and avoid unnecessary use of antibacterials agents. We describe the clinical, laboratory findings and outcome of serologically confirmed, hospitalized cases with DF in this paper.
MATERIAL AND METHODS
It is a prospective and observational study conduct ed between November 2010 to September 2012. We included all adult patients presenting with acute febrile illness with positive serological test for dengue antigen (NS1) or anti-dengue immunoglobulin M(Ig M) antibody. Patients with established infections, such as, malaria, enteric fever, bacterial sepsis, leptospirosis, chikungunya fever were excluded. Institutional Ethics Committee approval was taken before the initiation of study. Relevant history, clinical examination findings, laboratory data, and treatment details and outcome was collected from the patients after obtaining informed consent. 
Statistical analysis
Data are presented as mean ± standard deviation for continuous variables and proportions for categorical variables.
RESULTS
Of the 148 patients included in the study, 85 (57.4%) were males; 73% were < 40 years of age. Fifteen (10.1%) 45 (30.4%), 88 (59.46%) had DF (Group 1), DF with warning signs (Group 2), severe DF (Group 3) grades respect ively. There was no significant difference in the age distribution of these patients 32.8±15 years in males and 33.4±15 in females. There was significant seasonal distribution with nearly 95% admissions occurring in the second half of the year (July to December).
The clinical presentation (Table 1) included fever in all patients. Other symptoms were vomitings, headache, body pains, rash, loose stools, pain abdomen, jaundice, low back pain and retroorbital pain. Physical examination revealed rash, pallor, injected conjunctiva, Table 2 . Gastrointestinal bleeding was the most common bleeding manifestation (Table 2) . Neurological complications were seen in 9 (6%) of study patients which included acute demyelinating encephalomyelit is (ADEM), Guillain-Barre syndrome (GBS) and myelitis.
Elevation of hepatic transaminases was present in 105 (71%) of patients (Table 3A) . Of these 105 patients with hepatitis, 85 (81%) patients had mild to moderate hepatitis (up to ten-fold elevation) whereas the remaining 20 (19.1%) had severe hepatitis (>10-fold elevation). Hypoalbuminemia (serum albumin <3.5 g/dL) was present in 62 (42.9%) patients. Urine examination showed albuminuria (>2+) in 39 (26.4%) and microscopic haematuria in 49 (33.1%) patients. Elevated serum creatinine was seen in 6 (4.1%) patients.
Ultrasonographic examination of abdomen performed in 95 patients (Table 3B) Packed red cell transfusion was given to 14 (9.5%) patients all of whom had severe dengue. Platelet rich plasma (PRP) and single donor platelets (SDP) were given to 36 (24.3%) In our study 73% were patients aged <40 years, and male to female ratio was 1.8:1. This is possibly because young men go out doors for work, exposing themselves to mosquito bites as reported in other Indian studies. 10, 11 Up to 95% were admitted in second half of each year (July to December) which is consistent with vector breeding season. 12 Fever was a universal complaint followed by vomitings, loose motions, headache, and body pains. They may be confused with other febrile illnesses like viral gastroenteritis, typhoid and scrub typhus which are prevalent in our community. Loose stools were seen in 15 (11%) patients. Intestinal mucosal injury which may be responsible for loose motions in DF. 13 Pain abdomen in DF is a warning sign and mandates admission and close monitoring. Causes of pain abdomen in DF include stretching of liver capsule due to hepatitis, pancreatitis, acalculous cholecystitis and peptic ulcer. Pain abdomen was found in 20.3% of our study population and similar findings have been reported in literature. 14, 15 Higher incidence of pain abdomen up to 60% was noted in a study from Kerala. 11 Physical examination plays an important role in t he evaluation of a patient with DF. Hepatomegaly of more than 2 cm is a warning sign in severe grades of dengue according to WHO. Twenty three (15.5%) of our patients had hepatomegaly on clinical examination and all had severe DF. Presence of hepatomegaly is an important clue in t he out-patient department to admit a patient with suspected dengue. Splenomegaly was seen in 25 (16.9%) patients on physical examination and similar numbers were reported in another study from India. Figure  1A ) was observed in 47 (31.8%) patients. The rash was reported in 82% of cases in another study. 17 Lower incidence of rash in our patients could possibly difficulty in recognition due to dark skin colour. In some cases, individual lesions may coalesce and are seen as generalized confluent erythema with rounded islands of sparing ( Figure 1C ) described as "white islands in a sea of red". 18 WHO guidelines suggest that the intramuscular injections are contraindicated in patients with dengue infection. However, some of our pat ient s presented with int ramuscular haematoma ( Figure 1D ). This is because many of the clinicians did not diagnose the fever as DF and were not be aware of the patient's platelet count.
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In our study, 62 (41.9%) patients developed bleeding manifestations, of which melena was the most common bleeding manifestation. Similar findings were reported in a study from Kerala. 11 Bleeding manifestations were seen in 37% patients in a large series from Brazil. 19 A higher proportion of bleeding manifestations were noted by Sharma et al. 14 Lum et al 20 described hypotension as a strong predictor of severe bleeding. Two patients in our study had serious bleeding manifestations in the form of subdural haematoma (SDH) (Figure 2 ) in one and intracerebral bleeding in another. A high index of suspicion is required in patients with DF during convalescence regarding intracranial bleed when they present with altered sensorium. 21 Increased menstrual flow was noticed in 4 out of 63 female patients. Menorrhaghia has been described as a bleeding complication in DF in published literature. 22 Clinically evident pallor was noted in 37 (25%) patients in the present study which was confirmed by low haemoglobin in severe dengue grade compared to other grades, more so in females. This is possibly due to bleeding manifestations or pre-existing nutritional anaemia in the background. Leucopenia was present in 34% of our study population. Some authors reported leucopenia in 62% of patients with severe dengue possibly due to higher total leucocyte count cut-off values of 5000/cmm for defining thrombocytopenia. 23 Leucocytosis was found in 14% of our patients, mostly with severe dengue. Leucocytosis in dengue infection can indicate secondary bacterial infections. 24 Leucocytosis in six out of nine of their patients who had concurrent bacteraemia in a study. 24 Hepatic dysfunction is a well recognized feature of DF and occurs due to direct involvement of liver cells by dengue virus and by the unregulated host immune response against the virus. It is characterized by hepatomegaly and mild to moderate transaminasitis although jaundice and acute liver failure are uncommon. 20, 25 In our study, hepatitis was found in 80.9%, patients including severe hepatitis in 13% of patients. These findings were consistent with reports from another study. 26 We observed that AST elevation was greater than that of ALT in patients with mildto-moderate hepatitis, whereas, ALT elevation was higher than that of AST in patients with severe hepatitis. Severe hypoalbuminemia was found in 62 (41.9 %) of our patients and this was more evident in patients with severe DF. Liver function abnormalities have been found to be a predictor of mortality in DF in several studies. [27] [28] [29] [30] Our observations suggest that AST, ALT serum albumin levels need close monitoring in patients with DF. Presence of jaundice in patients with DF has been associated with liver failure and by itself is a poor prognostic factor. 30 Jaundice as a symptoms was noted in 7 of our patients while elevated bilirubin was found in 17 (11.5%) of our patients. Similar findings were reported in other studies. 16, 31 Most studies on the mechanisms of bleeding in DHF identified consumptive coagulopathy in a large proportion of cases. [32] [33] [34] [35] Coagulopathy is evident in patients with severe DF and shock and is manifested by a prolonged activated partial thromboplastin (aPTT) time. 32 Elevated aPPT was seen in 41% of the study patients. Albuminuria was found in 39 (26.4%) of our patients. Similar findings were reported in another study. 33 Microscopic haematuria was found in 49 (33.1%) of our patients, while a figure of 12.5% was reported in another study. 34 Renal injury comprising increase in serum creatinine, proteinuria, glomerulonephritis, acute kidney injury and haemolytic uremic syndrome have been reported in patients with DF. 35 In our study all patients with renal failure (n=9) had severe DF.
Chest radiographic abnormalities were seen in 37 (25%) of our patients. This included pleural effusion (n=31, 21%) (Figure 3) , bilateral infiltrates suggestive of ARDS (n=6, 4%). These abnormalities were found in patients with DF with warning signs and severe DF. In another study, 36 a found higher proportion (53%) of radiographic abnormalities were reported. 36 In another study 37 from China (n=606), ARDS was reported in 1.8% patients.
Ultrasonographic examination of abdomen and chest is useful for the early recognition of severe forms of DF. In our study 29 (19.5%) of the patients had evidence of ascites. Gall bladder wall thickness of more than 5 mm can be adopted as a criterion for identifying dengue patients at high risk for developing hypovolemic shock with a specificity of 92%. 38 Acalculous cholecystitis was found in 12% of our study patients, mostly in patients with severe DF. In a study 39 on pediatric patients with dengue infection, higher proportion had gall bladder wall oedema.
ECG changes in DF include sinus bradycardia, PR prolongation, ST segment elevation and non-specific ST-T changes. [40] [41] [42] Myocarditis in DF can manifest with complete AV block or ventricular arrhythmias, which manifest as syncope or palpitations. Most of these changes are transient and usually revert to normal. [40] [41] [42] During the the early part of infection i.e., during the febrile period, dengue virus can be diagnosed by virus isolation in specialized centers. Currently dengue infection can be diagnosed in the first one week of illness with the detection of NS1 antigen. Rapid dengue antigen detection tests can be used in field settings to detect infection in less than an hour. 1 During the primary infection with dengue virus, IgM antibody is the first immunoglobulin isotype to appear and will rise to detectable levels at around 7 days followed by Ig G antibody rise. In contrast during secondary dengue infection, Ig G antibody titers rise rapidly during the first week with lower titers of Ig M though detectable levels. In our study NS1 antigen was detected in 80 (54%) patients who presented to us with fever of less than one week. Rest of the patients who presented late were diagnosed by IgM antibody positivity.
Dengue virus is generally considered nonneurotropic, however, 5 fatal cases of dengue encephalopathy were reported in which dengue virus antigen was detected in the brain by immunohistochemistry. 43 There have been reports of neurological complications of dengue virus infection and include encephalitis, myelitis, GBS and myositis. [44] [45] [46] In our study neurological complications were seen in nine patients which included ADEM, GBS and myelitis.
Even though fluid management is the mainstay of treatment, there is no specific therapy for dengue fever. In a recent study 47 from India, Carica papaya leaf extract (CPLE) was found to increase the platelet count significantly in DF patients with thrombocytopenia. Further research is required in this area.
The WHO revised the terminology of dengue in year 2012 48 and included unusual manifestations in the form of severe organ involvement such as liver, kidneys, brain or heart. These unusual manifestations may be associated with co-infections, co-morbidities, or complications of prolonged shock. 48 Physicians must be aware of this entity and manage patients more closely.
Oral candidiasis was found in 23 (15.5%) of our patients. In a study 49 from Sri Lanka, oral candidiasis was reported in 18.3% of children wit h DF. The authors 49 described oral candidiasis as a new finding and proposed increased viral virulence as a cause for oral candidiasis. Transient immunosuppression and antibiotic use could be possible causes for oral candidiasis in patients with DF and this needs further research.
